Navigate the growing complexity of modern oncology trials with an imaging partner backed by over 30 years of clinical imaging expertise and experience supporting 350+ oncology clinical trials. Combining deep oncology knowledge with the latest advancements in Voiant Hub 2.0 and ReadReady™, Voiant helps sponsors streamline response assessment, manage complex efficacy and safety imaging requirements, and accelerating high-quality imaging endpoint delivery without compromising quality across solid tumor, hematologic malignancies, neuro-oncology, and other cancer types.
Oncology Imaging Capabilities
What's inside:
Oncology Response Assessment Expertise
Specialized oncology expertise across RECIST, RANO, and disease-specific assessment criteria for BICR and imaging services
Integrated Efficacy + Safety Imaging Workflows
Unified imaging read paradigms supporting efficacy evaluation, safety monitoring, and endpoint adjudication
Voiant Hub 2.0 and Voiant ReadReady™ for Oncology
AI-powered image flow optimization, rapid turnaround times, and real-time site feedback supporting confident clinical development decisions
Fill out the form below to download now:
"*" indicates required fields